Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response
Year: 2025
Type: article
Language: en
Topic: MRI in cancer diagnosis
Authors and affiliations:
raw_author_name: Daniel Navarro-Garcia
raw_affiliation_strings: Radiomics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Francesco Grussu
raw_affiliation_strings: Radiomics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Christina Zatse
raw_affiliation_strings: Radiomics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Niklas Klümper
raw_affiliation_strings: Department of Urology, UKB, Bonn, Germany
Institute of Experimental Oncology, UKB, Bonn, Germany
raw_author_name: Carlos Macarro
raw_affiliation_strings: Radiomics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Alberto Hernando-Calvo
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Marta Sanz
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Maria Vieito
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Irene Braña
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
Head & Neck Cancer Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Oriol Mirallas
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Guzmán Alonso
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Vladimir Galvao
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Giulia Pretelli
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Julia Lostes
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Arjun Oberoi
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Rodrigo Toledo
raw_affiliation_strings: Biomakers and Clonal Dynamics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Paolo Nuciforo
raw_affiliation_strings: Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Elena Garralda
raw_affiliation_strings: Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Raquel Perez-Lopez
raw_affiliation_strings: Radiomics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain